Acelyrin, Inc. (SLRN) Tops Q2 EPS by 22c

Acelyrin, Inc. (NASDAQ: SLRN) reported Q2 EPS of ($0.86), $0.22 better than the analyst estimate of ($1.08).

For earnings history and earnings-related data on Acelyrin, Inc. (SLRN) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• A.O. Smith executive chairman to retire, CEO to assume chairman role
• Edgewell stock surges on report of rejected takeover bid